PLTR reports Q1 2026 results on May 4 carrying a $350 billion market cap, a 92x P/E, and a consensus that remains divided — making the valuation story the sharpest edge heading into the number.
Bulls have plenty to work with. EPS momentum ranks in the 93rd percentile over the past 90 days, and PLTR has a track record of beating estimates — its EPS surprise factor scores in the 73rd percentile. Oppenheimer initiated coverage at Outperform with a $200 target just last month, and Wedbush has held firm at $230 throughout. The commercial AI narrative has real substance: Q4 2025 commercial revenue grew 137% year-on-year, and a $185 billion Golden Dome contract win adds headline fuel. The most recent analyst consensus mean target is $185, implying roughly 25% upside from current levels — a gap that reflects genuine optimism about Palantir's ability to monetise its AI platform at scale.
Bears focus on the arithmetic. At 92x earnings and an EV/EBITDA above 66x, the stock prices in years of near-perfect execution. Citigroup trimmed its target sharply — from $260 to $210 — last week while maintaining a Buy, a signal that even convinced bulls are recalibrating to a tougher tape. Revenue concentration and long, unpredictable government sales cycles are structural concerns that don't disappear with a strong quarter. Mizuho also cut its target from $195 to $185 in mid-April. The direction of travel among analysts who already own positive ratings is cautious: targets are coming down, not up.
The short-selling and options picture tells a quieter story. Short interest is modest at 2.35% of free float — up around 6% on the week but not a signal of aggressive conviction against the stock. Borrow is effectively free at 0.37% cost, down sharply over the past month, and availability is ample. The ORTEX short score of 29.9 is well within normal range. Options positioning is similarly neutral: the put/call ratio of 1.07 is fractionally below its 20-day average of 1.08, with a z-score near zero — no unusual hedging pressure in either direction. This is not a stock where short sellers are loudly expressing a view.
The earnings history adds one data point worth noting. The February 2026 print produced a sharp one-day gain of 7.7%, only for the stock to give back ground over the following week, closing the five-day window down 2.5%. The pattern — a relief rally quickly faded — reflects how sensitive the stock is to sentiment swings at this valuation level.
May 4's print is therefore primarily a valuation test: whether Q1 revenue growth and margin delivery justify a 92x multiple at a time when even supportive analysts are quietly lowering their sights.
See the live data behind this article on ORTEX.
Open PLTR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
